Uncovering the relationship between stroke and air pollution
New research focusing on the relationship between stroke and air [...]
Mental health elevating risk of stroke for young adults
According to a new study involving 6.5 million individuals, young [...]
Summit Spotlight Series: The Motek C-Mill
Summit Medical and Scientific would like to introduce you to their range of innovative rehabilitation technology in this short product series.
Study identifies new target for treating stroke
Stroke continues to be a major cause of mortality across [...]
MS treatment outlook: Interview with research leader Deborah Backus
NR Times meets leading neuroscientist and MS expert Deborah Backus about the boundary-pushing research taking place at the Shepherd Centre in Atlanta.
Deborah Backus, vice president of research and innovation at the Shepherd Centre, Atlanta, has dedicated her career to researching MS and spinal cord injury. She initially began studying motor control in monkeys, but after a “lightbulb moment” during her PhD in neuroscience, she realised she needed to do more to “help clinicians understand the scientific evidence and how it can inform their practice”. As director of MS research at the world-leading hospital, Dr Backus is putting this passion into practice. The Shepherd Centre treats people across the entire continuum of care, covering spinal cord injury, acquired and traumatic brain injury, MS and chronic pain. Alongside its clinical work, the centre also contains corresponding research departments which carry out clinical trials that seek to directly improve clinical knowledge and patients’ quality of life. Dr Backus speaks to NR Times about the importance of translating research into clinical research and how her career has been shaped by a passion for making research actionable.New breakthrough made for minimally invasive stroke treatment
Researchers have been able to display a minimally invasive stroke [...]
Learning from experiences: Folia Health CEO on working towards a better future for healthcare
The Folia Health app allows patients to be able to [...]
LISTEN HERE: New episode of the SR Times Podcast
After a short hiatus the SR Times Podcast returns for [...]
Could machine learning predict Huntington’s progression?
Scientists are using machine learning to analyse data collected from the world’s largest study of people with Huntington's disease.
Huntington’s disease is a complex condition to treat. There is no cure and no treatments that can alter its course. Its progression is hard to predict, but a new retrospective study shows how machine learning could play an important role in predicting its trajectory. The study was conducted by scientists at the University of Iowa Health Care, US biotech company Genentech and Roche Products, the company behind the development of a potential new therapy for HD, Tominersen. Read NR Times' interview with those behind the study to find out how machine learning could change Huntington's management.How common is cognitive impairment post-stroke?
According to a new scientific statement, it is believed that [...]
